Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited

Jill Koshiol, Allan Hildesheim, Paula Gonzalez, M. Concepcion Bratti, Carolina Porras, Mark Schiffman, Rolando Herrero, Ana C. Rodriguez, Sholom Wacholder, Meredith Yeager, Stephen J. Chanock, Robert D. Burk, Sophia S. Wang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. We analyzed common single nucleotide polymorphisms (SNP) across the TP53 locus in a population-based nested case-control study in Guanacaste, Costa Rica. We evaluated 11 SNPs, including Pro72Arg (rs1042522), among 1,281 women: 465 with cervical intraepithelial neoplasia grade 3/cancer (CIN3+), 380 with HPV persistence (median, 25 months), and 436 random population controls. We combined HPV persistence and CIN3+ into one case group because they did not differ in TP53 genotypic frequencies and calculated odds ratios and 95% confidence intervals (CI) for individual SNPs and inferred haplotypes. We observed that proline at codon 72 was associated with increased risk of CIN3+/persistence compared with population controls. Relative to GG (Arg), the CG (Pro/Arg) and CC (Pro) genotypes had a 1.3-fold (95% CI, 0.99-1.6) and 1.8-fold (95% CI, 1.2-2.7) increased risk, respectively (P trend < 0.01). rs12951053 and rs1642785 were also associated with CIN3+/persistence (P trend, 0.05 and 0.04, respectively), as was a haplotype containing the codon 72 variant (rs1042522), rs12951053, rs1642785, and rs12947788 (odds ratio, 1.6; 95% CI, 1.1-2.3 versus the most common haplotype, which comprised the major alleles for all 11 SNPs). Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism.

Original languageEnglish (US)
Pages (from-to)1631-1637
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Single Nucleotide Polymorphism
Codon
Confidence Intervals
Haplotypes
Population Control
Uterine Cervical Neoplasms
Neoplasms
Odds Ratio
Costa Rica
Cervical Intraepithelial Neoplasia
Natural History
Proline
Case-Control Studies
Alleles
Genotype
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. / Koshiol, Jill; Hildesheim, Allan; Gonzalez, Paula; Bratti, M. Concepcion; Porras, Carolina; Schiffman, Mark; Herrero, Rolando; Rodriguez, Ana C.; Wacholder, Sholom; Yeager, Meredith; Chanock, Stephen J.; Burk, Robert D.; Wang, Sophia S.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 5, 05.2009, p. 1631-1637.

Research output: Contribution to journalArticle

Koshiol, J, Hildesheim, A, Gonzalez, P, Bratti, MC, Porras, C, Schiffman, M, Herrero, R, Rodriguez, AC, Wacholder, S, Yeager, M, Chanock, SJ, Burk, RD & Wang, SS 2009, 'Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited', Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 5, pp. 1631-1637. https://doi.org/10.1158/1055-9965.EPI-08-0830
Koshiol, Jill ; Hildesheim, Allan ; Gonzalez, Paula ; Bratti, M. Concepcion ; Porras, Carolina ; Schiffman, Mark ; Herrero, Rolando ; Rodriguez, Ana C. ; Wacholder, Sholom ; Yeager, Meredith ; Chanock, Stephen J. ; Burk, Robert D. ; Wang, Sophia S. / Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 5. pp. 1631-1637.
@article{190cd067fa19495aac100921b0e47913,
title = "Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited",
abstract = "Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. We analyzed common single nucleotide polymorphisms (SNP) across the TP53 locus in a population-based nested case-control study in Guanacaste, Costa Rica. We evaluated 11 SNPs, including Pro72Arg (rs1042522), among 1,281 women: 465 with cervical intraepithelial neoplasia grade 3/cancer (CIN3+), 380 with HPV persistence (median, 25 months), and 436 random population controls. We combined HPV persistence and CIN3+ into one case group because they did not differ in TP53 genotypic frequencies and calculated odds ratios and 95{\%} confidence intervals (CI) for individual SNPs and inferred haplotypes. We observed that proline at codon 72 was associated with increased risk of CIN3+/persistence compared with population controls. Relative to GG (Arg), the CG (Pro/Arg) and CC (Pro) genotypes had a 1.3-fold (95{\%} CI, 0.99-1.6) and 1.8-fold (95{\%} CI, 1.2-2.7) increased risk, respectively (P trend < 0.01). rs12951053 and rs1642785 were also associated with CIN3+/persistence (P trend, 0.05 and 0.04, respectively), as was a haplotype containing the codon 72 variant (rs1042522), rs12951053, rs1642785, and rs12947788 (odds ratio, 1.6; 95{\%} CI, 1.1-2.3 versus the most common haplotype, which comprised the major alleles for all 11 SNPs). Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism.",
author = "Jill Koshiol and Allan Hildesheim and Paula Gonzalez and Bratti, {M. Concepcion} and Carolina Porras and Mark Schiffman and Rolando Herrero and Rodriguez, {Ana C.} and Sholom Wacholder and Meredith Yeager and Chanock, {Stephen J.} and Burk, {Robert D.} and Wang, {Sophia S.}",
year = "2009",
month = "5",
doi = "10.1158/1055-9965.EPI-08-0830",
language = "English (US)",
volume = "18",
pages = "1631--1637",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited

AU - Koshiol, Jill

AU - Hildesheim, Allan

AU - Gonzalez, Paula

AU - Bratti, M. Concepcion

AU - Porras, Carolina

AU - Schiffman, Mark

AU - Herrero, Rolando

AU - Rodriguez, Ana C.

AU - Wacholder, Sholom

AU - Yeager, Meredith

AU - Chanock, Stephen J.

AU - Burk, Robert D.

AU - Wang, Sophia S.

PY - 2009/5

Y1 - 2009/5

N2 - Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. We analyzed common single nucleotide polymorphisms (SNP) across the TP53 locus in a population-based nested case-control study in Guanacaste, Costa Rica. We evaluated 11 SNPs, including Pro72Arg (rs1042522), among 1,281 women: 465 with cervical intraepithelial neoplasia grade 3/cancer (CIN3+), 380 with HPV persistence (median, 25 months), and 436 random population controls. We combined HPV persistence and CIN3+ into one case group because they did not differ in TP53 genotypic frequencies and calculated odds ratios and 95% confidence intervals (CI) for individual SNPs and inferred haplotypes. We observed that proline at codon 72 was associated with increased risk of CIN3+/persistence compared with population controls. Relative to GG (Arg), the CG (Pro/Arg) and CC (Pro) genotypes had a 1.3-fold (95% CI, 0.99-1.6) and 1.8-fold (95% CI, 1.2-2.7) increased risk, respectively (P trend < 0.01). rs12951053 and rs1642785 were also associated with CIN3+/persistence (P trend, 0.05 and 0.04, respectively), as was a haplotype containing the codon 72 variant (rs1042522), rs12951053, rs1642785, and rs12947788 (odds ratio, 1.6; 95% CI, 1.1-2.3 versus the most common haplotype, which comprised the major alleles for all 11 SNPs). Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism.

AB - Driven by findings that human papillomavirus (HPV)-induced degradation of p53 differs by a TP53 polymorphism at codon 72 (Pro72Arg), past studies of TP53 genetic variants and cervical cancer have focused on this nonsynonymous polymorphism, with mixed results. We analyzed common single nucleotide polymorphisms (SNP) across the TP53 locus in a population-based nested case-control study in Guanacaste, Costa Rica. We evaluated 11 SNPs, including Pro72Arg (rs1042522), among 1,281 women: 465 with cervical intraepithelial neoplasia grade 3/cancer (CIN3+), 380 with HPV persistence (median, 25 months), and 436 random population controls. We combined HPV persistence and CIN3+ into one case group because they did not differ in TP53 genotypic frequencies and calculated odds ratios and 95% confidence intervals (CI) for individual SNPs and inferred haplotypes. We observed that proline at codon 72 was associated with increased risk of CIN3+/persistence compared with population controls. Relative to GG (Arg), the CG (Pro/Arg) and CC (Pro) genotypes had a 1.3-fold (95% CI, 0.99-1.6) and 1.8-fold (95% CI, 1.2-2.7) increased risk, respectively (P trend < 0.01). rs12951053 and rs1642785 were also associated with CIN3+/persistence (P trend, 0.05 and 0.04, respectively), as was a haplotype containing the codon 72 variant (rs1042522), rs12951053, rs1642785, and rs12947788 (odds ratio, 1.6; 95% CI, 1.1-2.3 versus the most common haplotype, which comprised the major alleles for all 11 SNPs). Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism.

UR - http://www.scopus.com/inward/record.url?scp=66649097624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66649097624&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0830

DO - 10.1158/1055-9965.EPI-08-0830

M3 - Article

C2 - 19423538

AN - SCOPUS:66649097624

VL - 18

SP - 1631

EP - 1637

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 5

ER -